Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Colorectal Neoplasms

Free Subscription Articles published in Anticancer Res Retrieve available abstracts of 77 articles: HTML format Text format

Single Articles

February 2012
1. SUN Z , Zhu Y, Wang PP, Roebothan B, et al
   Reported Intake of Selected Micronutrients and Risk of Colorectal Cancer: Results from a Large Population-based Case-control Study in Newfoundland, Labrador and Ontario, Canada.
   Anticancer Res. 2012;32:687-96.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. CHOI J , Chang H
   The Expression of MAGE and SSX, and Correlation of COX2, VEGF, and Survivin in Colorectal Cancer.
   Anticancer Res. 2012;32:559-64.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   January 2012
3. SIGGLEKOW ND , Pangon L, Brummer T, Molloy M, et al
   Mutated in Colorectal Cancer Protein Modulates the NFkappaB Pathway.
   Anticancer Res. 2012;32:73-9.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
4. KATO T , Nagata N, Fujii M, Takemoto H, et al
   Multi-center Phase II Study of FLOX for Advanced Colorectal Cancer Patients in Japan: SWIFT 3 Study.
   Anticancer Res. 2011;31:4657-64.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. SCHOPPMANN A , Tamandl D, Herberger B, Langle F, et al
   Comparison of Lymphangiogenesis between Primary Colorectal Cancer and Corresponding Liver Metastases.
   Anticancer Res. 2011;31:4605-11.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. MAEDA K , Hazama S, Tokuno K, Kan S, et al
   Impact of chemotherapy for colorectal cancer on regulatory T-cells and tumor immunity.
   Anticancer Res. 2011;31:4569-74.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
7. CHO YB , Chung HJ, Lee WY, Choi SH, et al
   Relationship between TYMS and ERCC1 mRNA Expression and In Vitro Chemosensitivity in Colorectal Cancer.
   Anticancer Res. 2011;31:3843-9.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. SREEVALSAN S , Joseph S, Jutooru I, Chadalapaka G, et al
   Induction of apoptosis by cannabinoids in prostate and colon cancer cells is phosphatase dependent.
   Anticancer Res. 2011;31:3799-807.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
9. 
   Colorectal cancer screening.
   Anticancer Res. 2011;31:3641.
   PubMed     Text format     Related articles   
   
   
   
   
10. CZEJKA M , Kiss A, Koessner C, Terkola R, et al
    Metabolic Activation of Irinotecan during Intra-arterial Chemotherapy of Metastatic Colorectal Cancer.
    Anticancer Res. 2011;31:3573-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. LEE SC , Cheong HJ, Kim SJ, Yoon J, et al
    Low-Dose Combinations of LBH589 and TRAIL Can Overcome TRAIL-resistance in Colon Cancer Cell Lines.
    Anticancer Res. 2011;31:3385-94.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. TUTINO V , Notarnicola M, Guerra V, Lorusso D, et al
    Increased soluble leptin receptor levels are associated with advanced tumor stage in colorectal cancer patients.
    Anticancer Res. 2011;31:3381-3.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. PAZDIORA P , Svobodova S, Fuchsova R, Kucera R, et al
    Vitamin d in colorectal, breast, prostate and lung cancer: a pilot study.
    Anticancer Res. 2011;31:3619-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. KOMORI K , Kanemitsu Y, Ishiguro S, Shimizu Y, et al
    Clinicopathological study of poorly differentiated colorectal adenocarcinomas: comparison between solid-type and non-solid-type adenocarcinomas.
    Anticancer Res. 2011;31:3463-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. SPENGLER G , Handzlik J, Ocsovszki I, Viveiros M, et al
    Modulation of multidrug efflux pump activity by new hydantoin derivatives on colon adenocarcinoma cells without inducing apoptosis.
    Anticancer Res. 2011;31:3285-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
16. TAFLIN H , Wettergren Y, Odin E, Carlsson G, et al
    Gene Polymorphisms MTHFRC677T and MTRA2756G as Predictive Factors in Adjuvant Chemotherapy for Stage III Colorectal Cancer.
    Anticancer Res. 2011;31:3057-62.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. SAIF MW , Kaley K, Penney R, Hotchkiss S, et al
    The Efficacy of Gemcitabine as Salvage Treatment in Patients with Refractory Advanced Colorectal Cancer (CRC): A Single Institution Experience.
    Anticancer Res. 2011;31:2971-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. HARADA Y , Kijima K, Shinmura K, Sakata M, et al
    Methylation of the Homeobox Gene, HOPX, Is Frequently Detected in Poorly Differentiated Colorectal Cancer.
    Anticancer Res. 2011;31:2889-92.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. KAIRA K , Okumura T, Ohde Y, Takahashi T, et al
    Prognostic significance of thymidylate synthase expression in the adjuvant chemotherapy after resection for pulmonary metastases from colorectal cancer.
    Anticancer Res. 2011;31:2763-71.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. YAGUBLU V , Arthur JR, Babayeva SN, Nicol F, et al
    Expression of selenium-containing proteins in human colon carcinoma tissue.
    Anticancer Res. 2011;31:2693-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
21. KINUGASA T , Akagi Y, Murotani K, Romeo K, et al
    Relationship between Ulcerative Colitis Patients Treated with Leukocytapheresis and Ulcerative Colitis-associated Colorectal Cancer.
    Anticancer Res. 2011;31:2547-52.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. SHIRATSUCHI I , Akagi Y, Kawahara A, Kinugasa T, et al
    Expression of IGF-1 and IGF-1R and Their Relation to Clinicopathological Factors in Colorectal Cancer.
    Anticancer Res. 2011;31:2541-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. YOSHIDA Y , Tsunoda T, Doi K, Tanaka Y, et al
    KRAS-mediated Up-regulation of RRM2 Expression Is Essential for the Proliferation of Colorectal Cancer Cell Lines.
    Anticancer Res. 2011;31:2535-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. HIGASHI D , Futami K, Ishibashi Y, Egawa Y, et al
    Clinical course of colorectal cancer in patients with ulcerative colitis.
    Anticancer Res. 2011;31:2499-504.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. HONDA T , Inagawa H, Yamamoto I
    Differential Expression of mRNA in Human Monocytes following Interaction with Human Colon Cancer Cells.
    Anticancer Res. 2011;31:2493-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. TSUNODA T , Takashima Y, Yoshida Y, Doi K, et al
    Oncogenic KRAS Regulates miR-200c and miR-221/222 in a 3D-Specific Manner in Colorectal Cancer Cells.
    Anticancer Res. 2011;31:2453-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. YOSHIDA T , Kinugasa T, Akagi Y, Kawahara A, et al
    Decreased expression of claudin-1 in rectal cancer: a factor for recurrence and poor prognosis.
    Anticancer Res. 2011;31:2517-25.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. FUJIMOTO T , Shirasawa S
    KRAS-induced actin-interacting protein: a potent target for obesity, diabetes and cancer.
    Anticancer Res. 2011;31:2413-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
29. DERWINGER K , Gustavsson B
    Variations in demography and prognosis by colon cancer location.
    Anticancer Res. 2011;31:2347-50.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. BOUCHE O , Maindrault-Goebel F, Ducreux M, Lledo G, et al
    Phase II Trial of Weekly Alternating Sequential BIBF 1120 and Afatinib for Advanced Colorectal Cancer.
    Anticancer Res. 2011;31:2271-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. WU F , Shirahata A, Sakuraba K, Kitamura Y, et al
    Down-regulation of EGFL8: A Novel Prognostic Biomarker for Patients with Colorectal Cancer.
    Anticancer Res. 2011;31:2249-54.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. TAIYOH H , Kubota T, Fujiwara H, Matsumura A, et al
    NK4 Gene Expression Enhances 5-Fluorouracil-induced Apoptosis of Murine Colon Cancer Cells.
    Anticancer Res. 2011;31:2217-24.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. NASIR A , Lopez A, Boulware D, Malafa M, et al
    Correlation between COX-2 and APC Expression in Left Versus Right-sided Human Colon Cancer.
    Anticancer Res. 2011;31:2191-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. PREWETT M , Bassi R, Paz K, Amatulli M, et al
    Estimating Preclinical Efficacy Targets Utilizing Cetuximab Efficacy in KRAS Mutant and Wild-type Colorectal Cancer Models.
    Anticancer Res. 2011;31:2149-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. LEE SJ , Lee HJ, Moon DH
    Quantitative analysis of thymidine kinase 1 and 5'(3')-deoxyribonucleotidase mRNA expression: the role of fluorothymidine uptake.
    Anticancer Res. 2011;31:2135-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
36. OCVIRK J , Rebersek M, Boc M
    Bevacizumab in First-line Therapy of Metastatic Colorectal Cancer: A Retrospective Comparison of FOLFIRI and XELIRI.
    Anticancer Res. 2011;31:1777-82.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. NAKAYAMA G , Kodera Y, Ohashi N, Koike M, et al
    p16INK4a Methylation in Serum as a Follow-up Marker for Recurrence of Colorectal Cancer.
    Anticancer Res. 2011;31:1643-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. GOCHMAN E , Mahajna J, Reznick AZ
    NF-{kappa}B Activation by Peroxynitrite through I{kappa}B{alpha}-dependent Phosphorylation versus Nitration in Colon Cancer Cells.
    Anticancer Res. 2011;31:1607-17.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. SCHNEGELSBERG B , Schumacher U, Valentiner U
    Lectin Histochemistry of Metastasizing and Non-metastasizing Breast and Colon Cancer Cells.
    Anticancer Res. 2011;31:1589-97.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. KAJIWARA Y , Ueno H, Hashiguchi Y, Shinto E, et al
    Heterogeneity of metalloproteinase expression in colorectal cancer - relation of molecular findings to basic morphology.
    Anticancer Res. 2011;31:1567-75.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. SINGH-RANGER G , Kumar D
    Current concepts in the non-operative management of rectal cancer after neoadjuvant chemoradiation.
    Anticancer Res. 2011;31:1795-800.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. CHOU ST , Peng HY, Chang CT, Yang JS, et al
    Zanthoxylum ailanthoides Sieb and Zucc. extract inhibits growth and induces cell death through G2/M-phase arrest and activation of apoptotic signals in colo 205 human colon adenocarcinoma cells.
    Anticancer Res. 2011;31:1667-76.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. HAVELUND BM , Sorensen FB, Lindebjerg J, Spindler KL, et al
    Pretreatment HIF-1alpha and GLUT-1 expressions do not correlate with outcome after preoperative chemoradiotherapy in rectal cancer.
    Anticancer Res. 2011;31:1559-65.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
44. DE BRUIJN MT , Raats DA, Tol J, Hinrichs J, et al
    Combined KRAS and TP53 Mutation Status Is Not Predictive in CAPOX-treated Metastatic Colorectal Cancer.
    Anticancer Res. 2011;31:1379-85.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. HOFMANN G , Langsenlehner U, Langsenlehner T, Glehr M, et al
    Single Nucleotide Polymorphisms of Integrin Alpha-2 and Beta-3 Genes Are not Associated with Relapse-free and Overall Survival in Colorectal Cancer Patients.
    Anticancer Res. 2011;31:1373-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. HIBI K , Goto T, Sakuraba K, Shirahata A, et al
    Methylation of OSMR Gene Is Frequently Observed in Non-invasive Colorectal Cancer.
    Anticancer Res. 2011;31:1293-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. BANDAPALLI OR , Hariri N, Macher-Goppinger S, Kahlert C, et al
    Increased apoptosis of host cells and tumor cells in the invasion front of colorectal liver metastases.
    Anticancer Res. 2011;31:1215-24.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
48. NOJIRI K , Tanaka K, Nagano Y, Ueda M, et al
    Efficacy of Surgery for Lung Metastases from Colorectal Cancer Synchronous to or Following that for Liver Metastases.
    Anticancer Res. 2011;31:1049-54.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. TZOVARAS AA , Karagiannis A, Margari C, Barla G, et al
    Effective Panitumumab Treatment in Patients with Heavily Pre-treated Metastatic Colorectal Cancer: A Case Series.
    Anticancer Res. 2011;31:1033-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. SIERKO E , Wojtukiewicz MZ, Zimnoch L, Thorpe PE, et al
    Co-localization of Prothrombin Fragment F1+2 and VEGF-R2-Bound VEGF in Human Colon Cancer.
    Anticancer Res. 2011;31:843-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. TANAKA M , Kataoka H, Mabuchi M, Sakuma S, et al
    Anticancer effects of novel photodynamic therapy with glycoconjugated chlorin for gastric and colon cancer.
    Anticancer Res. 2011;31:763-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. PATTA A , Fakih M
    First-line cisplatin plus etoposide in high-grade metastatic neuroendocrine tumors of colon and rectum (MCRC NET): review of 8 cases.
    Anticancer Res. 2011;31:975-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. SOREIDE K
    High-fidelity of five quasimonomorphic mononucleotide repeats to high-frequency microsatellite instability distribution in early-stage adenocarcinoma of the colon.
    Anticancer Res. 2011;31:967-71.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. SORBY LA , Kleiveland CR, Andersen SN, Bukholm IR, et al
    The endothelin axis in the metastatic process of colon carcinoma.
    Anticancer Res. 2011;31:861-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
55. THORSTEINSSON M , Soletormos G, Jess P
    Low Number of Detectable Circulating Tumor Cells in Non-metastatic Colon Cancer.
    Anticancer Res. 2011;31:613-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. KANG MJ , Jung SA, Jung JM, Kim SE, et al
    Associations between Single Nucleotide Polymorphisms of MMP2, VEGF, and HIF1A Genes and the Risk of Developing Colorectal Cancer.
    Anticancer Res. 2011;31:575-84.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. UEMURA M , Yamamoto H, Takemasa I, Mimori K, et al
    Hypoxia-inducible Adrenomedullin in Colorectal Cancer.
    Anticancer Res. 2011;31:507-14.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. LEA MA , Chacko J, Bolikal S, Hong JY, et al
    Addition of 2-deoxyglucose enhances growth inhibition but reverses acidification in colon cancer cells treated with phenformin.
    Anticancer Res. 2011;31:421-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. BHATTACHARYA A , Turowski SG, Martin ID, Rajput A, et al
    Magnetic Resonance and Fluorescence-Protein Imaging of the Anti-angiogenic and Anti-tumor Efficacy of Selenium in an Orthotopic Model of Human Colon Cancer.
    Anticancer Res. 2011;31:387-93.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. REDDAVIDE R , Misciagna G, Caruso MG, Notarnicola M, et al
    Tissue expression of glycated apolipoprotein B in colorectal adenoma and cancer.
    Anticancer Res. 2011;31:555-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. NAGATA T , Sakakura C, Komiyama S, Miyashita A, et al
    Expression of Cancer Stem Cell Markers CD133 and CD44 in Locoregional Recurrence of Rectal Cancer.
    Anticancer Res. 2011;31:495-500.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. DESITTER I , Guerrouahen BS, Benali-Furet N, Wechsler J, et al
    A new device for rapid isolation by size and characterization of rare circulating tumor cells.
    Anticancer Res. 2011;31:427-41.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
63. SVOBODOVA S , Topolcan O, Holubec L Jr, Levy M, et al
    Parameters of biological activity in colorectal cancer.
    Anticancer Res. 2011;31:373-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. FREYER G , Duret A, Milano G, Chatelut E, et al
    Pharmacogenetic Tailoring of Irinotecan-based First-line Chemotherapy in Metastatic Colorectal Cancer: Results of a Pilot Study.
    Anticancer Res. 2011;31:359-66.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. TAMURA S , Oshima T, Yoshihara K, Kanazawa A, et al
    Clinical Significance of STC1 Gene Expression in Patients with Colorectal Cancer.
    Anticancer Res. 2011;31:325-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. WONG NS , Fernando NH, Nixon AB, Cushman S, et al
    A Phase II Study of Capecitabine, Oxaliplatin, Bevacizumab and Cetuximab in the Treatment of Metastatic Colorectal Cancer.
    Anticancer Res. 2011;31:255-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. TRESKA V , Topolcan O, Vrzalova J, Skalicky T, et al
    Predictive value of serum biomarkers in patients after portal vein embolization (PVE): a pilot study.
    Anticancer Res. 2011;31:339-44.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. ADVANI PP , Fakih MG
    5-FU-induced hyperammonemic encephalopathy in a case of metastatic rectal adenocarcinoid successfully rechallenged with the fluoropyrimidine analog, capecitabine.
    Anticancer Res. 2011;31:335-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. KORKEILA E , Jaakkola PM, Syrjanen K, Pyrhonen S, et al
    Pronounced tumour regression after radiotherapy is associated with negative/weak glucose transporter-1 expression in rectal cancer.
    Anticancer Res. 2011;31:311-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. TAKEDA K , Kinoshita I, Shimizu Y, Matsuno Y, et al
    Expression of LGR5, an Intestinal Stem Cell Marker, During Each Stage of Colorectal Tumorigenesis.
    Anticancer Res. 2011;31:263-70.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. FADLALLA K , Watson A, Yehualaeshet T, Turner T, et al
    Ruta graveolens extract induces DNA damage pathways and blocks Akt activation to inhibit cancer cell proliferation and survival.
    Anticancer Res. 2011;31:233-41.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
72. FARKOUH A , Ettlinger D, Schueller J, Georgopoulos A, et al
    A rapid and simple HPLC assay for quantification of capecitabine for drug monitoring purposes.
    Anticancer Res. 2010;30:5207-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
73. ALDULAYMI B , Christensen IJ, Soletormos G, Jess P, et al
    Chemoradiation-induced changes in serum CEA and plasma TIMP-1 in patients with locally advanced rectal cancer.
    Anticancer Res. 2010;30:4755-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. BONMASSAR L , Fossile E, Scoppola A, Graziani G, et al
    Detection of circulating tumor cells is improved by drug-induced antigen up-regulation: preclinical and clinical studies.
    Anticancer Res. 2010;30:4721-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. DEMPKE WC , Heinemann V
    Ras mutational status is a biomarker for resistance to EGFR inhibitors in colorectal carcinoma.
    Anticancer Res. 2010;30:4673-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. WESOLOWSKA O , Wisniewski J, Bielawska-Pohl A, Paprocka M, et al
    Stilbenes as multidrug resistance modulators and apoptosis inducers in human adenocarcinoma cells.
    Anticancer Res. 2010;30:4587-93.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
77. OHTA K , Murata H, Mori Y, Ishima M, et al
    Remodeling of the tumor microenvironment by combined treatment with a novel radiosensitizer, {alpha}-sulfoquinovosylmonoacylglycerol ({alpha}-SQMG) and X-irradiation.
    Anticancer Res. 2010;30:4397-404.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: